News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
PUBLICATION

Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP.

March 16, 2005
Read More
PUBLICATION

Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice.

June 30, 2004
Read More
PUBLICATION

Juvenile 5HT(1B) receptor knockout mice exhibit reduced pharmacological sensitivity to 5HT(1A) receptor activation.

May 28, 2004
Read More
PUBLICATION

Application of triple-probe microdialysis for fast PK/PD evaluation of dopamimetic activity of drug candidates in the rat brain.

April 26, 2004
Read More
PUBLICATION

Striatal plasticity at the network level. Focus on adenosine A(2A) and D(2) interactions in models of Parkinson’s Disease.

March 20, 2004
Read More
PUBLICATION

Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats.

January 25, 2004
Read More
PUBLICATION

Stress-induced hyperthermia and anxiety: pharmacological validation.

June 30, 2003
Read More
PUBLICATION

In need of high-throughput behavioral systems.

July 7, 2002
Read More
PUBLICATION

Neuregulin 1 and susceptibility to schizophrenia.

June 30, 2002
Read More